Citation Impact
Citing Papers
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Autophagy in T cells from aged donors is maintained by spermidine and correlates with function and vaccine responses
2020
Current progress in development of hepatitis C virus vaccines
2013
Self-Amplifying mRNA Vaccines
2014
In Vivo Electroporation Enhances the Immunogenicity of Hepatitis C Virus Nonstructural 3/4A DNA by Increased Local DNA Uptake, Protein Expression, Inflammation, and Infiltration of CD3+ T Cells
2007
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms
2014
Prospects for Prophylactic and Therapeutic Vaccines Against Hepatitis C Virus
2012
Vaccination for hepatitis C virus: closing in on an evasive target
2011
Development and Optimization of a Real-Time Quantitative PCR-Based Method for the Titration of AAV-2 Vector Stocks
2002
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Animal Models for the Study of Hepatitis C Virus Infection and Related Liver Disease
2012
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Coinfection With HIV-1 and HCV—A One-Two Punch
2009
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Vaccination Against Hepatitis B and C: Towards Therapeutic Application
2009
Designing an HCV vaccine: a unique convergence of prevention and therapy?
2017
Hallmarks of aging: An expanding universe
2023 Standout
Hepatitis C vaccine: supply and demand
2008
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
2011
Delayed Induction, Not Impaired Recruitment, of Specific CD8+ T Cells Causes the Late Onset of Acute Hepatitis C
2011 StandoutNobel
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
2007
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection
2009
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Progress in Adeno-Associated Virus Type 2 Vector Production: Promises and Prospects for Clinical Use
1999
Immune Responses to HCV and Other Hepatitis Viruses
2014
Adaptive Immunity to the Hepatitis C Virus
2010
Successful Vaccination Induces Multifunctional Memory T-Cell Precursors Associated With Early Control of Hepatitis C Virus
2012
The long and winding road leading to the identification of the hepatitis C virus
2009 StandoutNobel
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control
2016
COVID-19 vaccines: breaking record times to first-in-human trials
2020
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Animal Models for Hepatitis C
2013
Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus Vector
2006
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?
2015
Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo
2002
Electroporation-enhanced delivery of nucleic acid vaccines
2014
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
2001
IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection
2012
Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice
2018
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
SARS-CoV-2 vaccines in development
2020 StandoutNature
Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates
2005
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Design and Packaging of Adeno-Associated Virus Gene Targeting Vectors
2000
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Development of hepatitis C virus vaccines: challenges and progress
2009
Will There Be a Vaccine to Prevent HCV Infection?
2014
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
2-Substituted Estradiol Bis-sulfamates, Multitargeted Antitumor Agents: Synthesis, In Vitro SAR, Protein Crystallography, and In Vivo Activity
2006
Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines
2007 StandoutNobel
Splicing Diversity of the Human OCLN Gene and Its Biological Significance for Hepatitis C Virus Entry
2010 StandoutNobel
Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman Primates
2017
Viral Vectors for Gene Therapy: Translational and Clinical Outlook
2015
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
The Frequency of CD127 + Hepatitis C Virus (HCV)-Specific T Cells but Not the Expression of Exhaustion Markers Predicts the Outcome of Acute HCV Infection
2013 StandoutNobel
Novel Infectious cDNA Clones of Hepatitis C Virus Genotype 3a (Strain S52) and 4a (Strain ED43): Genetic Analyses and In Vivo Pathogenesis Studies
2010
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1
2012
Emerging concepts in immunity to hepatitis C virus infection
2013
Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain
2008
Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus
2008
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules
2019 StandoutNobel
Works of Stefano Colloca being referenced
A chimpanzee serotype-based adenoviral vector as vaccine for CEA
2006
PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
2009
Construction of an rtTA2s-m2/ttskid-Based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and Non-Human primates
2003
Prime-boost vectored malaria vaccines: Progress and prospects
2010
Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming–boosting with novel adenoviral vectors based on different serotypes
2006
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
2006
A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaques
2006
An Adenovirus Type 5 (Ad5) Amplicon-Based Packaging Cell Line for Production of High-Capacity Helper-Independent ΔE1-E2-E3-E4 Ad5 Vectors
2005
Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
2017
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector
1999
Combined Adenovirus Vector and Hepatitis C Virus Envelope Protein Prime-Boost Regimen Elicits T Cell and Neutralizing Antibody Immune Responses
2014
Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults
2015
1051 PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
2009
The Kinetics of Hepatitis C Virus-Specific CD8 T-Cell Responses in the Blood Mirror Those in the Liver in Acute Hepatitis C Virus Infection
2008